The Kidney Not Taken: Single-Kidney Use in Deceased Donors.


Journal

Journal of the American College of Surgeons
ISSN: 1879-1190
Titre abrégé: J Am Coll Surg
Pays: United States
ID NLM: 9431305

Informations de publication

Date de publication:
01 Apr 2024
Historique:
medline: 18 3 2024
pubmed: 15 1 2024
entrez: 15 1 2024
Statut: ppublish

Résumé

The nonuse rate for kidneys recovered from deceased donors is increasing, rising to 27% in 2023. In 10% of these cases, 1 kidney is transplanted but the mate kidney is not. We conducted a retrospective, single-center cohort study from December 2001 to May 2023 comparing single kidneys transplanted at our center (where the contralateral kidney was not used) to kidneys where both were transplanted separately, at least 1 of which was at our center. We performed 395 single deceased-donor kidney transplants in which the mate kidney was not transplanted. Primary reasons for mate kidney nonuse were as follows: no recipient located or list exhausted (33.4%), kidney trauma or injury or anatomic abnormalities (18.7%), biopsy findings (16.7%), and poor renal function (13.7%). Mean donor and recipient ages were 51.5 ± 14.2 and 60 ± 12.6 years, respectively. Mean kidney donor profile index was 73% ± 22%, and 104 donors (26.3%) had kidney donor profile index >85%. Mean cold ischemia was 25.6 ± 7.4 hours, and 280 kidneys (70.7%) were imported. Compared with 2,303 concurrent control transplants performed at our center, primary nonfunction or thrombosis (5.1% single vs 2.8% control) and delayed graft function (35.4% single vs 30.1% control) were greater with single-kidney use (both p < 0.05). Median patient and death-censored graft survival were shorter in the single group (11.6 vs 13.5 years, p = 0.03 and 11.6 vs 19 years, p = 0.003), although the former was at least double median survival on the waiting list. In patients with functioning grafts in the single-kidney group, 1-year mean serum creatinine was 1.77 ± 0.8 mg/dL and estimated glomerular filtration rate was 44.8 ± 20 mL/min/1.73 m 2 . These findings suggest that many mate kidneys are being inappropriately rejected, given the acceptable outcomes that can be achieved by transplanting the single kidney in appropriately selected recipients.

Sections du résumé

BACKGROUND BACKGROUND
The nonuse rate for kidneys recovered from deceased donors is increasing, rising to 27% in 2023. In 10% of these cases, 1 kidney is transplanted but the mate kidney is not.
STUDY DESIGN METHODS
We conducted a retrospective, single-center cohort study from December 2001 to May 2023 comparing single kidneys transplanted at our center (where the contralateral kidney was not used) to kidneys where both were transplanted separately, at least 1 of which was at our center.
RESULTS RESULTS
We performed 395 single deceased-donor kidney transplants in which the mate kidney was not transplanted. Primary reasons for mate kidney nonuse were as follows: no recipient located or list exhausted (33.4%), kidney trauma or injury or anatomic abnormalities (18.7%), biopsy findings (16.7%), and poor renal function (13.7%). Mean donor and recipient ages were 51.5 ± 14.2 and 60 ± 12.6 years, respectively. Mean kidney donor profile index was 73% ± 22%, and 104 donors (26.3%) had kidney donor profile index >85%. Mean cold ischemia was 25.6 ± 7.4 hours, and 280 kidneys (70.7%) were imported. Compared with 2,303 concurrent control transplants performed at our center, primary nonfunction or thrombosis (5.1% single vs 2.8% control) and delayed graft function (35.4% single vs 30.1% control) were greater with single-kidney use (both p < 0.05). Median patient and death-censored graft survival were shorter in the single group (11.6 vs 13.5 years, p = 0.03 and 11.6 vs 19 years, p = 0.003), although the former was at least double median survival on the waiting list. In patients with functioning grafts in the single-kidney group, 1-year mean serum creatinine was 1.77 ± 0.8 mg/dL and estimated glomerular filtration rate was 44.8 ± 20 mL/min/1.73 m 2 .
CONCLUSIONS CONCLUSIONS
These findings suggest that many mate kidneys are being inappropriately rejected, given the acceptable outcomes that can be achieved by transplanting the single kidney in appropriately selected recipients.

Identifiants

pubmed: 38224100
doi: 10.1097/XCS.0000000000000968
pii: 00019464-202404000-00022
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

492-504

Informations de copyright

Copyright © 2024 by the American College of Surgeons. Published by Wolters Kluwer Health, Inc. All rights reserved.

Références

Organ Procurement & Transplantation Network. National data. Available at: https://optn.transplant.hrsa.gov/data/view-data-reports/national-data/# . Accessed October 31, 202.
Hart A, Patzer RE, Spear J, et al. Time to discard the term “discard”. Am J Transplant. 2023;23:608–610.
Israni AK, Zaun D, Gauntt K, et al. OPTN/SRTR 2021 annual data report: deceased organ donation. Am J Transplant. 2023;2:S443–S474.
Aubert O, Reese PP, Audry B, et al. Disparities in acceptance of deceased donor kidneys between the United States and France and estimated effects of increased US acceptance. JAMA Intern Med. 2019;179:1365–1374.
Ibrahim M, Vece G, Mehew J, et al. An international comparison of deceased donor kidney utilization: what can the United States and the United Kingdom learn from each other? Am J Transplant. 2020;20:1309–1322.
Mohan S, Yu M, King KL, Husain SA. Increasing discards as an unintended consequence of recent changes in United States allocation policy. Kidney Int Rep. 2023;8:1109–1111.
Formica RN, Schold JD. The unintended consequences of changes to the organ allocation policy. J Am Soc Nephrol. 2023;34:14–16.
Metzger R, Delmonico FL, Feng S, et al. Expanded criteria donors for kidney transplantation. Am J Transplant. 2003;3:114–125.
Massie AB, Desai NM, Montgomery RA, et al. Improving distribution efficiency of hard-to-place deceased donor kidneys: predicting probability of discard or delay. Am J Transplant. 2010;10:1613–1620.
Bae S, Massie AB, Luo X, et al. Changes in discard rate after the introduction of the Kidney Donor Profile Index (KDPI). Am J Transplant. 2016;16:2202–2207.
Crannell WC, Perkins JD, Leca N, Kling CE. Deceased donor kidneys are discarded at higher rates when labeled as high kidney donor profile index. Am J Transplant. 2022;22:3087–3092.
Mohan S, Chiles MC, Patzer RE, et al. Factors leading to the discard of deceased donor kidneys in the United States. Kidney Int. 2018;94:187–198.
Stewart DE, Garcia VC, Rosendale JD, et al. Diagnosing the decades-long rise in the deceased donor kidney discard rate in the United States. Transplantation. 2017;101:575–587.
Marrero WJ, Naik AS, Friedewald JJ, et al. Predictors of deceased donor kidney discard in the United States. Transplantation. 2017;101:1690–1697.
Cooper M, Formica R, Friedewald J, et al. Report of national kidney foundation consensus conference to decrease kidney discards. Clin Transplant. 2019;33:e13419.
Brennan C, Husain SA, King KL, et al. A donor utilization index to assess the utilization and discard of deceased donor kidneys perceived as high risk. Clin J Am Soc Nephrol. 2019;14:1634–1641.
Al-Shraideh YA, Farooq U, Farney AC, et al. Influence of recipient age on deceased donor kidney transplant outcomes in the expanded criteria donor era. Clin Transplant. 2014;28:1372–1382.
Reese PP, Harhay MN, Abt PL, et al. New solutions to reduce discard of kidneys donated for transplantation. J Am Soc Nephrol. 2016;27:973–980.
Stewart ZA, Shah SA, Formica RN, et al. A call to action: feasible strategies to reduce the discard of transplantable kidneys in the United States. Clin Transplant. 2020;34:e13990.
King KL, Chaudhry SG, Ratner LE, et al. Declined offers for deceased donor kidneys are not an independent reflection of organ quality. Kidney360. 2021;2:1807–1818.
Assfalg V, Miller G, Stocker F, et al. Kidney transplantation after rescue allocation—the Eurotransplant experience: a retrospective multicenter outcome analysis. Transplantation. 2022;106:1215–1226.
Noreen SM, Klassen D, Brown R, et al. Kidney accelerated placement project: outcomes and lessons learned. Am J Transplant. 2022;22:210–221.
Ashiku L, Dagli C. Identify hard-to-place kidneys for early engagement in accelerated placement with a deep learning optimization approach. Transplant Proc. 2022;55:38–48.
King KL, Husain SA, Perotte A, et al. Deceased donor kidneys allocated out of sequence by organ procurement organizations. Am J Transplant. 2022;22:1372–1381.
King KL, Husain SA, Yu M, et al. Characterization of transplant center decisions to allocate kidneys to candidates with lower waiting list priority. JAMA Netw Open. 2023;6:e2316936.
Bodzin AS, Leiby BE, Ramirez CB, et al. Expanded criteria donor kidneys where the paired kidney is discarded owing to biopsy results: a concept that needs revision. Exp Clin Transplant. 2014;6:499–505.
Husain SA, Chiles MC, Lee S, et al. Characteristics and performance of unilateral kidney transplants from deceased donors. Clin J Am Soc Nephrol. 2018;13:118–127.
Sonnenberg EM, Hsu JY, Cohen JB, et al. Acute kidney injury in deceased organ donors and kidney transplant outcomes. Ann Surg. 2022;276:e982–e990.
Ibrahim M, Mehew J, Martin K, et al. Outcomes of declined deceased donor kidney offers that are subsequently implanted: a UK registry study. Transplantation. 2023;107:1348–1358.
Rao PS, Schaubel DE, Guidinger MK, et al. A comprehensive risk quantification score for deceased donor kidneys: the kidney donor risk index. Transplantation. 2009;88:231–236.
Stratta RJ, Sundberg AK, Rohr MS, et al. Optimal utilization of older donors and recipients in kidney transplantation. Surgery. 2006;139:324–333.
Carpenter D, Husain SA, Brennan C, et al. Procurement biopsies in the evaluation of deceased donor kidneys. Clin J Am Soc Nephrol. 2018;13:1876–1885.
Orlando G, Khan MA, El-Hennawy H, et al. Is prolonged cold ischemia a contraindication to using kidneys from acute kidney injury donors? Clin Transplant. 2018;32:e13185.
Harriman DI, Kazokov H, Rogers J, et al. Does prolonged cold ischemia affect outcomes in donation after cardiac death donor kidney transplants? Clin Transplant. 2022;36:e14628.
Stratta RJ, Moore PS, Farney AC, et al. Influence of pulsatile perfusion preservation on outcomes in kidney transplantation from expanded criteria donors. J Am Coll Surg. 2007;204:873–882; discussion 882.
Farney AC, Hines MH, Al-Geizawi ST, et al. Lessons learned from a single center experience with 134 donation after cardiac death deceased donor kidney transplants. J Am Coll Surg. 2011;212:440–451; discussion 451.
Khan MA, El-Hennawy H, Farney AC, et al. Analysis of local versus imported expanded criteria donor kidneys: a single-center experience with 497 ECD kidney transplants. Clin Transplant. 2017;31:e13029.
Werenski H, Stratta RJ, Sharda B, et al. Single center experience transplanting deceased donor kidneys with poor perfusion parameters. J Am Coll Surg. 2023;236:848–857.
Farooq U, Al-Shraideh Y, Farney AC, et al. Deceased donor kidney transplantation in patients aged 70 and older: is 70 the new 50? J Gerontol Geriatr Res. 2016;5:1–8.
Farney AC, Doares W, Rogers J, et al. A randomized trial of alemtuzumab versus antithymocyte globulin induction in renal and pancreas transplantation. Transplantation. 2009;88:810–819.
Schold J, Srinivas TR, Sehgal AR, Meier-Kriesche HU. Half of kidney transplant candidates who are older than 60 years now placed on the waiting list will die before receiving a deceased-donor transplant. Clin J Am Soc Nephrol. 2009;4:1239–1245.
Lentine KL, Smith JM, Miller JM, et al. OPTN/SRTR 2021 annual data report: kidney. Am J Transplant. 2023;23:S21–S120.
Rana A, Gruessner A, Agopian VG, et al. Survival benefit of solid-organ transplant in the United States. JAMA Surg. 2015;150:252–259.
Stratta RJ. Kidney utility and futility. Clin Transplant. 2022;36:e14847.
Reddy NA, Reyad AI, Allam SR. The art and science of kidney transplant offer evaluation. Cureus. 2023;15:e43223.
Stratta RJ, Jay CL. Discretionary list diving optimizes kidney utilization. Am J Transplant. 2024;24:149–150.
Adler JT, Husain SA, King KL, Mohan S. Greater complexity and monitoring of the new kidney allocation system: implications and unintended consequences of concentric circle kidney allocation on network complexity. Am J Transplant. 2021;21:2007–2013.
Mohan S, Yu M, King K, Husain S. Increasing discards as an unintended consequence of recent changes in us kidney allocation policy. Kidney Int Rep. 2023;8:1109–1111.

Auteurs

Emily Ke McCracken (EK)

From the Department of Surgery, Section of Transplantation (McCracken, Jay, Garner, Webb, Farney, Orlando, Stratta).

Colleen L Jay (CL)

From the Department of Surgery, Section of Transplantation (McCracken, Jay, Garner, Webb, Farney, Orlando, Stratta).

Matthew Garner (M)

From the Department of Surgery, Section of Transplantation (McCracken, Jay, Garner, Webb, Farney, Orlando, Stratta).

Christopher Webb (C)

From the Department of Surgery, Section of Transplantation (McCracken, Jay, Garner, Webb, Farney, Orlando, Stratta).

Alan C Farney (AC)

From the Department of Surgery, Section of Transplantation (McCracken, Jay, Garner, Webb, Farney, Orlando, Stratta).

Giuseppe Orlando (G)

From the Department of Surgery, Section of Transplantation (McCracken, Jay, Garner, Webb, Farney, Orlando, Stratta).

Amber Reeves-Daniel (A)

Department of Internal Medicine, Section of Nephrology (Reeves-Daniel, Mena-Gutierrez, Sakhovskaya), Atrium Health Wake Forest Baptist, Winston-Salem, NC.

Alejandra Mena-Gutierrez (A)

Department of Internal Medicine, Section of Nephrology (Reeves-Daniel, Mena-Gutierrez, Sakhovskaya), Atrium Health Wake Forest Baptist, Winston-Salem, NC.

Natalia Sakhovskaya (N)

Department of Internal Medicine, Section of Nephrology (Reeves-Daniel, Mena-Gutierrez, Sakhovskaya), Atrium Health Wake Forest Baptist, Winston-Salem, NC.

Robert J Stratta (RJ)

From the Department of Surgery, Section of Transplantation (McCracken, Jay, Garner, Webb, Farney, Orlando, Stratta).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH